PCBL Chemical Ltd Q1 FY27 Earnings Call: Reiterates 14-15% EBITDA per Ton Guidance, Specialty Volumes Grow 23%

PCBL Chemical Ltd held its Q1 FY27 earnings call on July 29, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Headline Financials & Key Metrics

• Consolidated revenue of Rs.2,474 Cr — grew 17% YoY in Q1 FY 2026-2027, driven by domestic carbon black and specialty volumes.
• EBITDA of Rs.400 Cr — up 23% YoY, with EBITDA margin expanding ~80 bps; PAT of Rs.155 Cr surged 65% YoY.
• Domestic carbon black sales volume of 1,02,985 tons — up 15% YoY; international volumes were 50,528 tons, deliberately reallocated to domestic spot market for better margins.
• Specialty sales volume of 19,748 tons — grew 23% YoY in Q1 FY 2026-2027, with 70% of specialty carbon black volumes exported to strategic customers.
• Brent crude averaged US$97/bbl — vs. US$78 in Q4 FY 2025-2026, impacting raw material costs and contributing to a ~Rs.70 Cr inventory gain in Q1.

Volume, Realization & Margin Dynamics

• Overall realizations rose ~20% QoQ — translating to a Rs.27,000 per tonne sequential increase in Q1 FY 2026-2027; of this, Rs.11,000-Rs.12,000 was attributed to improved margin capture in the spot market (30% of sales), with the balance as cost pass-through.
• EBITDA per ton for carbon black came in at Rs.22,900 — management reiterated full-year FY 2026-2027 guidance of 14-15% improvement over the FY 2025-2026 average EBITDA of Rs.16,500-Rs.17,000 per ton.
• Managed gross profit per kg of ~Rs.36-37 — guided for the remaining nine months of FY 2026-2027, reflecting pricing discipline over volume after a tactical Q1 volume decline.
• Commissioned a 20,000 MTPA specialty black line at Mundra — taking total carbon black capacity to 900,000 MTPA; a 1,000 MTPA superconducting specialty black facility in Palaij commenced market development.
• Cost savings of Rs.200-250 Cr targeted — over the next four to six quarters (from Q1 FY 2026-2027) through feedstock diversification and operational efficiency programs.
• Q1 volume declined QoQ and YoY — due to a tactical choice to avoid low-margin international orders amid elevated logistics costs, and to defer sales until formula pricing caught up, maximizing inventory gains.

Segment Performance & Growth Strategy

• AquaPharm reported Q1 FY 2026-2027 sales volumes of 22,985 metric tons — revenue of Rs.394 Cr and EBITDA of Rs.47 Cr; EBITDA per kg at Rs.20/kg (Rs.20,000 per tonne), similar to Q1 FY 2025-2026 levels.
• Application-specific solutions grew 10% YoY — while oil & gas declined 35% YoY but rebounded 50% sequentially, indicating turnaround momentum; home care and water solutions volumes decreased marginally YoY.
• Green chelates order booking is ahead of current capacity — with qualifications ongoing at key accounts including P&G, Reckitt, and Henkel; management is in discussions for a new green chelates facility.
• Epofarm (phosphonate) segment commercial launches qualified — expected to drive revenue and margin growth over the next three quarters (by end of Q4 FY 2026-2027), supported by Tier 1/Tier 2 customer penetration in Europe.
• New three-year antiscalant contract won in the Gulf region — active customer conversations continue for desalination via seawater reverse osmosis positioning in Saudi Arabia and the Gulf.
• Raw material availability and NPG supply pressures affected Q1 — a small surcharge was in place during Q1 but is not assumed for the remainder of FY 2026-2027; management is working to de-risk the supply chain through alternative vendors and backward integration evaluation.
• Renewed geopolitical friction in the Americas slowed near-term oil & gas demand — management expects a pick-up in subsequent quarters, with major oil & gas product impact likely in FY 2027-2028.

EBITDA Bridge, Inventory & Power Business

• Inventory gain of ~Rs.70 Cr in Q1 FY 2026-2027 — with an estimated reversal of Rs.40-50 Cr in Q2 FY 2026-2027 as low-cost inventory is consumed; management noted this was an extraordinary benefit unlikely to recur in subsequent quarters.
• Power EBITDA jumped to Rs.110 Cr — vs. Rs.80 Cr in Q4 FY 2025-2026, driven by 50% higher realizations at Rs.5.39/unit compared to Rs.3.66/unit in the prior quarter.
• Tariff refund application filed for Rs.40-45 Cr — across Aquaform and PCBL, expected within 2-4 weeks; accounting treatment remains pending.
• CBFS-CBO price differential remained close to $150 per tonne — with CBO higher in Q1 FY 2026-2027; CBO prices also moved up following the CBFS price increase, contrary to expectations of stable CBO pricing.
• Logistics costs remain elevated — due to the Middle East crisis; surcharges are partially recovered from customers and not fully pass-through, with volatility expected to persist in Q2 FY 2026-2027.

Volume, Capex & Near-Term Outlook

• High single-digit volume growth guidance reiterated for FY 2026-2027 — despite Q1 softness, management attributed the lag to domestic customers pushing volumes into Q2 FY 2026-2027 as a timing issue.
• FY 2026-2027 EBITDA per ton guidance of 14–15% improvement — over the FY 2025-2026 average of Rs.16,500-Rs.17,000 per ton, supported by pricing discipline and cost initiatives.
• Capex outlook of ~Rs.300 Cr (±Rs.50 Cr) for FY 2026-2027 — primarily for maintenance and productivity enhancement, as brownfield expansion is largely complete; strategic capex limited to ~Rs.100 Cr, with most spending on efficiency programs.
• Greenfield Andhra facility spend largely in FY 2027-2028 — management noted the coal tar distillation project is under review, with capex approval expected by end of Q2 FY 2026-2027.
• Near-term volatility from geopolitical issues in the neighborhood — primarily impacting logistics costs and causing intermittent volume loss from port disruptions; management remains constructive on H2 FY 2026-2027.
• Q2 FY 2026-2027 temporary volume impact expected — due to cautious customer procurement; management expects a pick-up in the second half of the fiscal year.

Battery Materials, New Products & Geographies

• Nanowaste pilot plant is operational — first batch expected within weeks; customer sampling for battery materials expected in August 2026 (Q2 FY 2026-2027); long-term EBITDA target of Rs.1,000 Cr maintained, with R&D facilities in India, Australia, and Europe.
• Structural tailwinds cited from India's expanding trade agreements — management highlighted "India's expanding trade agreements (US, EU, UK, EFTA, Oman, NZ), tariff advantage in US market, and contraction in Russian refining and carbon black exports" as long-term growth drivers.
• US carbon black market expected to see significant growth — as new annual contracts are negotiated, followed by EU growth; exports to Europe were 15,000 tons and USA 4,800 tons in Q1 FY 2026-2027, with management prioritizing domestic market for higher value per ton.
• Oil & gas portfolio expansion underway — with approval for expansion into New Mexico (US), Latin America efforts underway, and Europe in planning; major product impact expected in FY 2027-2028.
• Coal tar distillation being explored as incremental value chain addition — a firm investment plan is expected in the next couple of months (period unspecified), with raw material sourcing considered feasible.
• Phosphonate segment facing European customer shift to green chelates — while tailwinds persist in Asia; oil & gas demand remains non-linear with customer inventory overhang reported.